Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.

Author: BishopJeffrey, CookEdwin H, KittlesRick, NewcornJeffrey, SteinMark A, WaldmanIrwin

Paper Details 
Original Abstract of the Article :
OBJECTIVES: This study seeks to determine if variation in the dopamine transporter gene (SLC6A3/DAT1) moderates the dose-response effects of long-acting dexmethylphenidate (D-MPH) and mixed amphetamine salts (MAS) in children with attention-deficit/hyperactivity disorder (ADHD). METHODS: Fifty-six ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064733/

データ提供:米国国立医学図書館(NLM)

Unlocking the Secrets of ADHD Treatment: The Dopamine Transporter's Role

The realm of [psychiatry] is continually seeking to refine [treatment strategies] for [attention-deficit/hyperactivity disorder (ADHD)]. This study delves into the genetic underpinnings of [ADHD] and explores the relationship between [dopamine transporter genotype] and the effectiveness of [stimulant medication]. The authors investigate the [dose-response effects] of [long-acting dexmethylphenidate (D-MPH)] and [mixed amphetamine salts (MAS)], uncovering a significant connection between [genotype] and [treatment outcomes].

Individualized Treatment: A Tailored Approach to ADHD

The authors' findings provide valuable insights into the [individualized nature of ADHD treatment]. Their research demonstrates that [genetic variations] can influence [drug response] and highlight the importance of considering [individualized treatment plans] based on [genotype]. This discovery underscores the need for a more personalized approach to [ADHD] management.

A New Horizon for ADHD Treatment: The Promise of Precision Medicine

This study offers a glimpse into the future of [ADHD] treatment. The authors' exploration of [genotype-specific drug response] paves the way for [precision medicine] approaches tailored to the unique needs of each patient. By incorporating [genetic testing] into [clinical practice], we can optimize treatment outcomes and enhance the quality of life for individuals with [ADHD].

Dr. Camel's Conclusion

Just like a camel adapts to its environment by seeking out the most suitable water source, individuals with [ADHD] require personalized treatment approaches. This research highlights the importance of considering [genetic factors] in tailoring treatment plans. By embracing this individualized approach, we can create a more effective and compassionate path to recovery for those living with [ADHD].

Date :
  1. Date Completed 2015-02-07
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24813374

DOI: Digital Object Identifier

PMC4064733

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.